Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 2/20 | 0.39 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.39 |
| ▸ | GABRP | O00591 | 1/20 | 0.39 |
| ▸ | GABRD | O14764 | 1/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.39 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.39 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.39 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.39 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15894553 | 0.94 | TSHR (0.65) | TSHRCYP1A2ALDH1A1GAAPKM | |
| SCHEMBL10349441 | 0.92 | TSHR (0.68) | TSHRCYP1A2ALDH1A1GAAPKM | |
| SCHEMBL1012361 | 0.92 | TSHR (0.68) | TSHRCYP1A2ALDH1A1GAAPKM | |
| SCHEMBL24809503 | 0.92 | TSHR (0.68) | TSHRCYP1A2ALDH1A1GAAPKM | |
| SCHEMBL9003670 | 0.92 | TSHR (0.68) | TSHRCYP1A2ALDH1A1GAAPKM | |
| Hydrochloric Acid SCHEMBL29193092 | 0.90 | TSHR (0.66) | TSHRCYP1A2ALDH1A1GAAPKM | |
| SCHEMBL88550 | 0.87 | — | — | |
| Ethylenediamine SCHEMBL7747400 | 0.87 | TSHR (0.55) | TSHRCYP1A2ALDH1A1GAAPKM | |
| SCHEMBL463195 | 0.87 | TSHR (0.70) | TSHRCYP1A2ALDH1A1GAAPKM | |
| SCHEMBL153651 | 0.87 | TSHR (0.77) | TSHRCYP1A2ALDH1A1GAAPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3739002-B1 | PHOTOVOLTAIC ENCAPSULATION MATERIAL WITH HIGH LIGHT TRANSMITTANCE | HANGZHOU FIRST APPLIED MAT CO LTD (CN) | 2024-01-17 | — | — | EP | claimed |
| US-11525043-B2 | High light transmittance photovoltaic encapsulating material | HANGZHOU FIRST APPLIED MATERIAL CO., LTD. (CN) | 2022-12-13 | — | — | US | claimed |
| US-20210115204-A1 | HIGH LIGHT TRANSMITTANCE PHOTOVOLTAIC ENCAPSULATING MATERIAL | HANGZHOU FIRST APPLIED MATERIAL CO., LTD. (CN) | 2021-04-22 | — | — | US | claimed |
| EP-3739002-A1 | PHOTOVOLTAIC ENCAPSULATION MATERIAL WITH HIGH LIGHT TRANSMITTANCE | Hangzhou First Applied Material Co., Ltd. (CN) | 2020-11-18 | — | — | EP | claimed |
| CN-108264682-B | A kind of photovoltaic encapsulation material of high transparency | 杭州福斯特应用材料股份有限公司 | 2019-11-15 | — | — | CN | claimed |
| EP-1753419-B1 | Anticancer and antiprotozoal dihydroartemisinin and dihydroartemisitene dimers with desirable chemical functionalities | UNIV MISSISSIPPI (US) | 2014-01-15 | — | — | EP | claimed |
| US-7842720-B2 | Anticancer and antiprotozoal dihydroartemisinene and dihydroartemisitene dimers with desirable chemical functionalities | ELSOHLY LABORATORIES, INCORPORATED (US) | 2010-11-30 | — | — | US | claimed |
| US-20080275106-A1 | Anticancer and Antiprotozoal Dihydroartemisinene and Dihydroartemisitene Dimers with Desirable Chemical Functionalities | THE UNIVERSITY OF MISSISSIPPI (US) | 2008-11-06 | — | — | US | claimed |
| EP-1753419-A1 | ANTICANCER AND ANTIPROTOZOAL DIHYDROARTEMISINENE AND DIHYDROARTEMISITENE DIMERS WITH DESIRABLE CHEMICAL FUNCTIONALITIES | University of Mississippi (US) | 2007-02-21 | — | — | EP | claimed |
| WO-2006002105-A1 | ANTICANCER AND ANTIPROTOZOAL DIHYDROARTEMISINENE AND DIHYDROARTEMISITENE DIMERS WITH DESIRABLE CHEMICAL FUNCTIONALITIES | UNIVERSITY OF MISSISSIPPI (US) | 2006-01-05 | — | — | WO | claimed |
| EP-3274322-B1 | STABLE COMPOSITIONS FOR PREVENTION / PROPHYLACTIC TREATMENT OF POISON IVY DERMATITIS | THE UNIV OF MISSISSIPPI (US) | 2024-08-14 | — | — | EP | disclosed |
| EP-3739002-B1 | PHOTOVOLTAIC ENCAPSULATION MATERIAL WITH HIGH LIGHT TRANSMITTANCE | HANGZHOU FIRST APPLIED MAT CO LTD (CN) | 2024-01-17 | — | — | EP | disclosed |
| US-11746114-B2 | Thermally sensitive protecting groups for cysteine for peptide cyclization and selective disulfide bond formation | UNIVERSITY OF WINDSOR (CA) | 2023-09-05 | — | — | US | disclosed |
| US-11746114-B2 | Thermally sensitive protecting groups for cysteine for peptide cyclization and selective disulfide bond formation | UNIVERSITY OF WINDSOR (CA) | 2023-09-05 | — | — | US | disclosed |
| US-11746114-B2 | Thermally sensitive protecting groups for cysteine for peptide cyclization and selective disulfide bond formation | UNIVERSITY OF WINDSOR (CA) | 2023-09-05 | — | — | US | disclosed |
| WO-2006002105-A1 | ANTICANCER AND ANTIPROTOZOAL DIHYDROARTEMISINENE AND DIHYDROARTEMISITENE DIMERS WITH DESIRABLE CHEMICAL FUNCTIONALITIES | UNIVERSITY OF MISSISSIPPI (US) | 2006-01-05 | — | — | WO | disclosed |
| EP-1416934-A4 | PROTEIN KINASE INHIBITORS COMPRISING ATP MIMETICS CONJUGATED TO PEPTIDES OR PEPTIDOMIMETICS | PEPTOR LTD (IL) | 2005-11-02 | — | — | EP | disclosed |
| US-20050026840-A1 | Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or pertidomimetics | CUREGENICS LTD. (IL) | 2005-02-03 | — | — | US | disclosed |
| EP-1416934-A2 | PROTEIN KINASE INHIBITORS COMPRISING ATP MIMETICS CONJUGATED TO PEPTIDES OR PEPTIDOMIMETICS | Peptor Ltd. (IL) | 2004-05-12 | — | — | EP | disclosed |
| WO-2003010281-A2 | PROTEIN KINASE INHIBITORS COMPRISING ATP MIMETICS CONJUGATED TO PEPTIDES OR PEPTIDOMIMETICS | PEPTOR LTD. (IL) | 2003-02-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080275106-A1 | Anticancer and Antiprotozoal Dihydroartemisinene and Dihydroartemisitene Dimers with Desirable Chemical Functionalities | DHPS, DHODH, HCCS | TSHR 4813/4885CYP1A2 1347/4885ALDH1A1 1448/4885 |
| US-11746114-B2 | Thermally sensitive protecting groups for cysteine for peptide cyclization and selective disulfide bond formation | PTMS, CTH, VIP | TSHR 2842/4885CYP1A2 3756/4885ALDH1A1 351/4885 |
| US-20050026840-A1 | Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or pertidomimetics | PRKCQ, ADK, PRKCH | TSHR 3247/4885CYP1A2 4860/4885ALDH1A1 4840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.